JP Patent

JP6206987B2 — 網膜剥離の処置のための生体適合性ヒドロゲル製剤

Assigned to メディカス バイオサイエンシーズ，エルエルシー · Expires 2017-10-04 · 9y expired

What this patent protects

Patent listed against berdazimer-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP6206987B2
Jurisdiction
JP
Classification
—
Expires
2017-10-04
Drug substance claim
No
Drug product claim
No
Assignee
メディカス バイオサイエンシーズ，エルエルシー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.